BIOLASE ANNOUNCES SUPPORT FOR PROJECT HOME
BIOLASE (NASDAQ: BIOL) has partnered with Project HOME, a Philadelphia-based organization dedicated to providing dental and healthcare services to individuals in need, regardless of their ability to pay. As part of this collaboration, BIOLASE donated an iPlus Waterlase laser system and will offer training to Project HOME staff. This initiative aims to enhance the quality of dental care provided and improve health outcomes for underserved populations. BIOLASE's commitment underscores its mission to deliver advanced dental laser technology and contribute positively to community health.
- Donation of an iPlus Waterlase laser system to Project HOME enhances dental care standards.
- Training program for Project HOME staff to improve treatment efficiency.
- Partnership aligns with BIOLASE's mission to improve community health outcomes.
- Potential for increased exposure and brand recognition within underserved communities.
- None.
LAKE FOREST, Calif., June 27, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has partnered with Project HOME, an organization that provides dental services to patients from their first birthday to adulthood. Project HOME's Healthcare Services is a Federally Qualified Health Center (FQHC) and supports health care services, regardless of a person's ability to pay for the services, in Philadelphia.
The mission of Project HOME is to empower adults, children, and families to break the cycle of homelessness and poverty, alleviate the underlying causes of poverty, and enable individuals to attain their fullest potential as individuals and as members of the broader society. Project HOME strives to create a safe and respectful environment to support individuals struggling with self-esteem, recovery, confidence, as well as mental and physical health.
Project HOME's dental services are part of a patient-centered, integrated health care service model, where many dental patients are also primary care patients. This allows medical issues that may impact oral health to be identified early and for treatment to begin to improve the patients' overall well-being.
During a ride-along with the BIOLASE team in Philadelphia, BIOLASE's President and Chief Executive Officer, John Beaver, was invited to visit Project HOME to see how the company could assist people in need. "At BIOLASE, our goal is to develop dental laser technology that provides a higher standard of care to the patient and improves patients' oral health," said Beaver. "Supporting Project HOME in their mission gives BIOLASE an opportunity to make a meaningful contribution to the overall health of the community."
"It is a great honor that BIOLASE has partnered with Project HOME to help provide dental care to our members. With the donation of an iPlus Waterlase laser system and the training program offered to our doctors and staff at Project HOME's dental facility in Philadelphia, the modern technology offered by BIOLASE will help provide a new standard of care for Project HOME members," commented Dr. Janine Burkhardt, Project HOME's Dental Director. "Improving the already excellent care each member receives, while assisting the doctors to complete more treatments in one visit, will have a significant impact on our ability to achieve our mission and improve our members' oral health outcomes."
Since 1989, Project HOME has helped thousands of people break the cycle of homelessness and poverty by providing a continuum of care that includes street outreach, supportive housing and comprehensive services that focus on health care, education and employment through both adult and youth education and enrichment programs. To learn more, visit www.projecthome.org.
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 32 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements regarding the anticipated roll out of new go-to-market sales strategies, the Company's efforts to achieve its goal of becoming EBITDA positive. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations and speak only as of the date of this release. Actual results may differ materially from BIOLASE's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described, from time-to-time, in the "Risk Factors" section of BIOLASE's annual reports filed on Form 10-K with the Securities and Exchange Commission. Except as required by law, BIOLASE does not undertake any responsibility to revise or update any forward-looking statements.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-announces-support-for-project-home-301575465.html
SOURCE BIOLASE, Inc.
FAQ
What is BIOLASE's recent partnership about?
What technology did BIOLASE donate to Project HOME?
How will BIOLASE support Project HOME?
What is the significance of the partnership for BIOLASE?
What types of services does Project HOME provide?
